Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Jakob CEM, Borgmann S, Duygu F, Behrends U, Hower M, Merle U, Friedrichs A, Tometten L, Hanses F, Jung N, Rieg S, Wille K, Grüner B, Klinker H, Gersbacher-Runge N, Hellwig K, Eberwein L, Dolff S, Rauschning D, von Bergwelt-Baildon M, Lanznaster J, Strauß R, Trauth J, de With K, Ruethrich M, Lueck C, Nattermann J, Tscharntke L, Pilgram L, Fuhrmann S, Classen A, Stecher M, Schons M, Spinner C, Vehreschild JJ. Jakob CEM, et al. Among authors: klinker h. Infection. 2021 Feb;49(1):63-73. doi: 10.1007/s15010-020-01499-0. Epub 2020 Oct 1. Infection. 2021. PMID: 33001409 Free PMC article.
Neurologic manifestations of COVID-19 in critically ill patients: results of the prospective multicenter registry PANDEMIC.
Dimitriadis K, Meis J, Neugebauer H, Barlinn K, Neumann B, Gahn G, Lochner P, Knier B, Lindemann S, Sühs KW, Szabo K, Pfefferkorn T, Schirotzek I, Freilinger T, Burc B, Günther A, Wittstock M, Schramm P, Reimann G, Godau J, Nagy G, Koenig FB, Essig F, Klinker H, Hartmann C, Schmidbauer ML, Steinberg T, Lefterova L, Klose C, Bösel J; IGNITE study group. Dimitriadis K, et al. Among authors: klinker h. Crit Care. 2022 Jul 16;26(1):217. doi: 10.1186/s13054-022-04080-3. Crit Care. 2022. PMID: 35842675 Free PMC article.
DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function.
Madurka I, Vishnevsky A, Soriano JB, Gans SJ, Ore DJS, Rendon A, Ulrik CS, Bhatnagar S, Krishnamurthy S, Mc Harry K, Welte T, Fernandez AA, Mehes B, Meiser K, Gatlik E, Sommer U, Junge G, Rezende E; Study group. Madurka I, et al. Infection. 2023 Jun;51(3):641-654. doi: 10.1007/s15010-022-01904-w. Epub 2022 Sep 14. Infection. 2023. PMID: 36104613 Free PMC article. Clinical Trial.
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study.
Spinner CD, Kümmerle T, Schneider J, Cordes C, Heiken H, Stellbrink HJ, Krznaric I, Scholten S, Jensen B, Wyen C, Viehweger M, Lehmann C, Sprinzl M, Stoehr A, Bickel M, Jessen H, Obst W, Spornraft-Ragaller P, Khaykin P, Wolf E, Boesecke C; DUALIS Study Group. Spinner CD, et al. Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa356. doi: 10.1093/ofid/ofaa356. eCollection 2020 Sep. Open Forum Infect Dis. 2020. PMID: 32965277 Free PMC article.
Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study.
Weidlich S, Boesecke C, Schneider J, Klinker HHF, Zink A, Balogh A, Wolf E, Bidner H, Spinner CD; DUALIS study team. Weidlich S, et al. Among authors: klinker hhf. J Antimicrob Chemother. 2020 Oct 1;75(10):3082-3084. doi: 10.1093/jac/dkaa234. J Antimicrob Chemother. 2020. PMID: 32634214 Free PMC article. No abstract available.
220 results